The research team has achieved significant growth and progress in the development and commercial promotion of the “Combined Semiconductor Chip Platform for COVID-19 Epidemic Prevention and Testing System”. This success has enabled the technology to be effectively commercialized and introduced into the market, providing valuable assistance in COVID-19 prevention and the early screening of other infectious diseases. The system plays a crucial role in epidemic control and infection prevention, contributing to the overall efforts in managing and containing the COVID-19 pandemic and other potential infectious outbreaks in the future.
On a technical development level, the research team has achieved significant breakthroughs in improving the yield of mass production and successfully developed a microfluidic water-absorbing cartridge. They have also made advancements in the development of electrochemical testing instruments and the integration with the IoT platform. On the commercial promotion front, the team has obtained ISO13485 medical device quality management system certification, which has strengthened their capabilities and plans to enter the international medical product supply chain. This certification effectively facilitates the expansion of their product into the global medical equipment market.
The team has already engaged with customers in Singapore and is planning to conduct pre-clinical and clinical trials in the country. Once they obtain certification in Singapore, they aim to promote their product in other Southeast Asian countries such as Malaysia, Indonesia, and Thailand. This expansion strategy demonstrates the team’s commitment to reaching a broader market and contributing to the COVID-19 prevention and management efforts in the region.